1[1]Fedele L, Arcaini L, Vercellini P, et al. Serum CA-125 levels in the diagnosis of endometriosis recurrence. Obstet Gynecol, 1988,72:9～22 被引量：1
2[2]Koninckx PR, Meuleman C, Demeyere S, et al. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril, 1991, 55(4):759～65 被引量：1
3石一复主编..子宫内膜异位症[M].上海:上海科学技术出版社,2002:255.
4[4]Chen FP, Soong YK, Lee N, et al. The use ot serum CA-125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand, 1998,77:665～670 被引量：1
5[5]Nagamani M, Kelver ME, Smith ER. CA 125 levels in monitoring therapy for endometriosis and in prediction of recurrence. Int J Fertil, 1992,37:227～231 被引量：1
6[6]Garzetti GG,Ciavattini A,Tranquilli AL,et al. Serum CA125 concerntration in Endometriosis patients:role of pelvic and peritoneal irritation. Gynecol Endocrinol,1994,8:27～31 被引量：1
7[7]Nieto A, Tacuri C, Serra M, et al. Long-term follow-up of endometriosis after two different therapies (Gestrinone and Buserelin). Clin Exp Obstet Gynecol,1996,23:198～204 被引量：1
8[8]Clayton RD, Hawe JA, Love JC, et al. Recurrent pain after hysterectomy and bilateral salpingo-oophorectomy for endometriosis: evaluation of laparoscopic excision of residual endometriosis. Br J Obstet Gynaecol, 1999, 106(7):740～744 被引量：1
9[9]Namnoum AB,Hickman TN,Goodman SB,et al. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril, 1995,64(5): 898～902 被引量：1
